Literature DB >> 17485468

A novel modulatory mechanism of transforming growth factor-beta signaling through decorin and LRP-1.

Claudio Cabello-Verrugio1, Enrique Brandan.   

Abstract

Transforming growth factor-beta (TGF-beta) is a multifunctional cytokine that signals to the nucleus through cell surface transmembrane receptors with serine/threonine kinase activity and cytoplasmic effectors, including Smad proteins. Here we describe two novel modulators of this pathway, lipoprotein-receptor related protein (LRP-1) and decorin. Decorin null (Dcn null) myoblasts showed a diminished TGF-beta response that is restored by decorin re-expression. Importantly, this reactivation occurs without changes in the binding to TGF-beta receptors, Smad protein phosphorylation, or Smad-4 nuclear translocation. In wild type myoblasts, inhibition of decorin binding to LRP-1 and depletion of LRP-1 inhibited TGF-beta response to levels similar to those observed in Dcn null myoblasts. Re-expression of decorin in Dcn null myoblasts cannot restore TGF-beta response if the Smad pathway or phosphatidylinositol 3-kinase activity is inhibited, suggesting that this LRP-1-decorin modulatory pathway requires activation of the Smad pathway by TGF-beta and involves phosphatidylinositol 3-kinase activity. This work unveils a new regulatory mechanism for TGF-beta signaling by decorin and LRP-1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17485468     DOI: 10.1074/jbc.M700243200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

1.  Aortic Valve Regurgitation: Pathophysiology and Implications for Surgical Intervention in the Era of TAVR.

Authors:  Filippo Ravalli; Alexander P Kossar; Hiroo Takayama; Juan B Grau; Giovanni Ferrari
Journal:  Struct Heart       Date:  2020-01-23

2.  TGF beta2-induced changes in LRP-1/T beta R-V and the impact on lysosomal A beta uptake and neurotoxicity.

Authors:  Pirooz Eslami; Ming F Johnson; Ellen Terzakaryan; Carolyn Chew; Marni E Harris-White
Journal:  Brain Res       Date:  2008-09-10       Impact factor: 3.252

Review 3.  Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction.

Authors:  Liliana Schaefer; Renato V Iozzo
Journal:  J Biol Chem       Date:  2008-05-06       Impact factor: 5.157

Review 4.  Decoding the Matrix: Instructive Roles of Proteoglycan Receptors.

Authors:  Thomas Neill; Liliana Schaefer; Renato V Iozzo
Journal:  Biochemistry       Date:  2015-07-22       Impact factor: 3.162

5.  Decorin is processed by three isoforms of bone morphogenetic protein-1 (BMP1).

Authors:  Zofia von Marschall; Larry W Fisher
Journal:  Biochem Biophys Res Commun       Date:  2009-12-22       Impact factor: 3.575

Review 6.  Proteoglycans in liver cancer.

Authors:  Kornélia Baghy; Péter Tátrai; Eszter Regős; Ilona Kovalszky
Journal:  World J Gastroenterol       Date:  2016-01-07       Impact factor: 5.742

Review 7.  Decorin interacting network: A comprehensive analysis of decorin-binding partners and their versatile functions.

Authors:  Maria A Gubbiotti; Sylvain D Vallet; Sylvie Ricard-Blum; Renato V Iozzo
Journal:  Matrix Biol       Date:  2016-09-30       Impact factor: 11.583

8.  Fibromodulin and Biglycan Modulate Periodontium through TGFβ/BMP Signaling.

Authors:  L Wang; B L Foster; V Kram; F H Nociti; P M Zerfas; A B Tran; M F Young; M J Somerman
Journal:  J Dent Res       Date:  2014-06-25       Impact factor: 6.116

9.  Matrix metalloproteinase-2-deficient fibroblasts exhibit an alteration in the fibrotic response to connective tissue growth factor/CCN2 because of an increase in the levels of endogenous fibronectin.

Authors:  Cristian A Droppelmann; Jaime Gutiérrez; Cecilia Vial; Enrique Brandan
Journal:  J Biol Chem       Date:  2009-03-09       Impact factor: 5.157

10.  Inhibition of extracellular matrix assembly induces the expression of osteogenic markers in skeletal muscle cells by a BMP-2 independent mechanism.

Authors:  Nelson Osses; Juan Carlos Casar; Enrique Brandan
Journal:  BMC Cell Biol       Date:  2009-10-05       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.